Rockville-based Neuralstem Inc. (NYSEMKT:CUR) reported a wider annual loss on higher research and development expenses. Neuralstem, Inc. (NYSEMKT:CUR) stock opened at $3.61 in last session, and closed at $3.90, while the day range of stock was $3.60 -$3.93. The stock showed a positive weekly performance of 10.17%.
Albany Molecular Research Inc. (NASDAQ:AMRI)’s move into Buffalo remains delayed, but a state official is optimistic that the drug-development company will be up and running by April in temporary space on the Buffalo Niagara Medical Campus. Albany Molecular Research, Inc. (NASDAQ:AMRI) stock opened at $17.01, in last session and closed at $18.81, by gaining 9.49%. The 52 week range of the stock is $8.92 – $18.95. Company’s market capitalization is $594.35 million.
Equities researchers at Leerink Swann raised their price objective on shares of Enanta Pharmaceuticals (NASDAQ:ENTA) from $29.00 to $45.00 in a research report issued on Monday, Analyst RN reports. Enanta Pharmaceuticals Inc (NASDAQ:ENTA) stock advanced 7.11% and finished the last session at $40.85. The EPS of the stock remained -2.77. Company’s market capitalization is $750.15 million.
IGI Laboratories, Inc. (NYSEMKT:IG) a generic topical pharmaceutical company, has received its first approval from the US Food and Drug Administration (FDA) for an abbreviated new drug application (ANDA). The FDA has approved IGI’s application for lidocaine hydrochloride USP 4% topical solution. IGI Laboratories, Inc. (NYSEMKT:IG) stock opened the session at $4.92, and closed the session at $5.17. The 52 week range of the stock remained $1.24 – $5.20 and the day range was $4.80 – $5.20.
Leave a Reply